Abstract
Using physicochemical property-driven optimization, twelve new diarylaniline compounds (DAANs) (7a-h, 11a-b and 12a-b) were designed and synthesized. Among them, compounds 12a-b not only showed high potency (EC50 0.96-4.92 nM) against both wild-type and drug-resistant viral strains with the lowest fold change (FC 0.91 and 5.13), but also displayed acceptable drug-like properties based on aqueous solubility and lipophilicity (LE>0.3, LLE>5, LELP<10). The correlations between potency and physicochemical properties of these DAAN analogues are also described. Compounds 12a-b merit further development as potent clinical trial candidates against AIDS.
Keywords:
Anti-HIV agents; Diarylaniline; NNRTIs; Physicochemical property.
Copyright © 2014 Elsevier Ltd. All rights reserved.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aniline Compounds / chemical synthesis
-
Aniline Compounds / chemistry
-
Aniline Compounds / pharmacology*
-
Anti-HIV Agents / chemical synthesis
-
Anti-HIV Agents / chemistry
-
Anti-HIV Agents / pharmacology*
-
Chemistry, Physical
-
Dose-Response Relationship, Drug
-
HIV Reverse Transcriptase / antagonists & inhibitors*
-
HIV Reverse Transcriptase / metabolism
-
HIV-1 / drug effects*
-
Microbial Sensitivity Tests
-
Molecular Structure
-
Reverse Transcriptase Inhibitors / chemical synthesis
-
Reverse Transcriptase Inhibitors / chemistry
-
Reverse Transcriptase Inhibitors / pharmacology*
-
Structure-Activity Relationship
Substances
-
Aniline Compounds
-
Anti-HIV Agents
-
Reverse Transcriptase Inhibitors
-
HIV Reverse Transcriptase